FDA recognizes the increased use of AI throughout the drug development process and across a range of therapeutic areas. Learn more.
Similar Posts
TITAN SARMS LLC – 719645 – 12/12/2025
Unapproved New DrugsRegulatory Education for Industry (REdI) Annual Conference 2024: Innovation in Medical Product Development – 05/29/2024
Regulatory Education for Industry (REdI) Annual Conference 2024: Innovation in Medical Product DevelopmentEyeTech One, LLC – 712438 – 07/09/2025
Unapproved New Drugs/MisbrandedLiquid Bicarbonate Concentrate Recall: Nipro Removes MedicaLyte Liquid Bicarbonate Concentrate due to Contamination
Nipro recalls bicarbonate dialysate concentrate due to contamination. Learn about potential serious injuries, fatality risks and essential steps for healthcare providers and patients for this Class I recall.ByHeart Inc. dba BlendHouse Allerton. Allerton, IA. EIR issued 06/28/2023
Task Description Request Please post to the OII FOIA Electronic Reading Room
Record Date 06/28/2023
Short Title (70 char) ByHeart Inc. dba BlendHouse Allerton. Allerton, IA. EIR issued 06/28/2023
FEI Number 1921383
Firm Name ByHeart Inc. dba BlendHouse Allerton
Record Type EIR
State IA
EstablishmentGepotidacin – Oral Products
Gepotidacin – Oral Products